It is just my opinion but if Avecho had any serious discussion going on about propofol partnership before issuing of CR then mcnamara would have easily invested more than a million during CR or if there was any serious buyer then CR could be postponed until after propofol announcement so IMO nothing exciting would come out of quarterly report... !
It will be disappointing to see propofol sit on shelf and management enjoy options issued after propofol announcement..
Ann: Improved Propofol TPM Formulation Passes Toxicology Study, page-133
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 34784472 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 34738413 | 20 |
View Market Depth
| Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable